ExoCoBio Completes Acquisition of BENEV, a Global Medical Aesthetic Brand

">With the acquisition of BENEV, ExoCoBio solidifies its position as a global leader in exosome-based regenerative aesthetics. This strategic partnership allows ExoCoBio to further expand the commercialization of exosome technology on a global scale. BENEV, a renowned medical aesthetic brand established in 2000, has been at the forefront of the industry. Their groundbreaking growth factor-based ..